Media Thread, page-7198

The untapped solid tumour market is worth US$400bn+ in the next few years. Just 5% of that market will equal US$20bn+ annually. Less humongous cost of 50% leaves gross profit of US$10bn. At PE of just 15, IMU will have a market cap of US150bn. That is more than 100 bags of current market cap/share price.

And that above is based on very, very conservative assumptions. No wonder some one posted recently about an analyst valuing a cure for cancer at $50 trillion.

Meanwhile, IMU is going cheap at under 20 cents. Get them while it last, I say.

DYOR as above just my wild opinion only.